arrow
V

Valentina Gaidano

University of Turin
H指数:15
被引数:769

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting Dihydroorotate Dehydrogenase (hDHODH) beyond the barrier: discovery of MEDS700 as blood-brain barrier permeable hDHODH inhibitor

靶向二氢乳清酸脱氢酶(hDHODH)突破屏障:发现MEDS700作为可透过血脑屏障的hDHODH抑制剂

2026-04-270
PRE
FLT3 alterations and inhibition in triple negative B-cell adult acute lymphoblastic leukemia patients
2024-03-220
PRE
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety br
2022-09-2614
OAAI
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia
2022-06-305
OAAI
Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience
LEUKEMIA
IF13.4
2022-05-2116
OAAI
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients

血液系统恶性肿瘤患者对SARS-CoV-2感染的中和体液反应模式揭示了未接受抗癌治疗的患者的强大免疫反应

2022-01-187
OAAI
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety
2021-04-1222
OAAI
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
2021-03-1113
OAAI
SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience
2020-09-2310
OAAI
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study
2020-06-0813
OAAI
Chronic myeloid leukemia stem cells
LEUKEMIA
IF13.4
2019-05-24141
OAAI
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors (vol 61, pg 6034, 2018)
2019-01-290
OAAI
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors
2018-06-2571
OAAI
Disabled gene is involved in CML progression and its expression level at diagnosis can predict major molecular response (MMR) to imatinib therapy
2010-04-010
PRE
Genome-wide screening for dominant modifiers in Drosophila identified new genes involved in BCR-ABL signaling and chronic myeloid leukemia (CML) progression
2010-04-010
PRE